{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:39:45Z","timestamp":1787668785572,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DREAM"},{"name":"NIH","award":["U19AI113127"],"award-info":[{"award-number":["U19AI113127"]}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"crossref","award":["R01DK107806"],"award-info":[{"award-number":["R01DK107806"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejpb.2018.05.030","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T09:29:10Z","timestamp":1527154150000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema"],"prefix":"10.1016","volume":"138","author":[{"given":"Thuy","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit A.","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo Ortiz","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Wei","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrine","family":"Bensouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Marzinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-8665","authenticated-orcid":false,"given":"Craig","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-2717","authenticated-orcid":false,"given":"Sanjeev","family":"Gumber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Villinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Cone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2018.05.030_b0005","unstructured":"Prevention Gap Report, Joint United Nations Programme on HIV\/AIDS (UNAIDS), 2016."},{"key":"10.1016\/j.ejpb.2018.05.030_b0010","unstructured":"HIV Among Gay and Bisexual Men, Centers for Disease Control and Prevention (CDC), 2017."},{"key":"10.1016\/j.ejpb.2018.05.030_b0015","unstructured":"CDC Fact Sheet: HIV among Gay and Bisexual Men, Centers for Disease Control and Prevention, 2017."},{"key":"10.1016\/j.ejpb.2018.05.030_b0020","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ije\/dyq057","article-title":"HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention","volume":"39","author":"Baggaley","year":"2010","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.ejpb.2018.05.030_b0025","doi-asserted-by":"crossref","unstructured":"P.L. Anderson, D.V. Glidden, A. Liu, S. Buchbinder, J.R. Lama, J.V. Guanira, V. McMahan, L.R. Bushman, M. Casapia, O. Montoya-Herrera, V.G. Veloso, K.H. Mayer, S. Chariyalertsak, M. Schechter, L.G. Bekker, E.G. Kallas, R.M. Grant, T. iPrEx Study, Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men, Sci. Transl. Med., 4 (2012) 151ra125.","DOI":"10.1126\/scitranslmed.3004006"},{"key":"10.1016\/j.ejpb.2018.05.030_b0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/apc.2012.0355","article-title":"An event-level comparison of risk-related sexual practices between black and other-race men who have sex with men: condoms, semen, lubricant, and rectal douching","volume":"27","author":"Calabrese","year":"2013","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.ejpb.2018.05.030_b0035","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1111\/j.1743-6109.2011.02438.x","article-title":"Sexual behaviors and situational characteristics of most recent male-partnered sexual event among gay and bisexually identified men in the United States","volume":"8","author":"Rosenberger","year":"2011","journal-title":"J. Sex Med."},{"key":"10.1016\/j.ejpb.2018.05.030_b0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2013.09.030","article-title":"Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design","volume":"155","author":"Hendrix","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejpb.2018.05.030_b0045","article-title":"Rectal douching associated with receptive anal intercourse: a literature review","author":"Carballo-Dieguez","year":"2017","journal-title":"AIDS Behav."},{"key":"10.1016\/j.ejpb.2018.05.030_b0050","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/OLQ.0b013e3181bf9b2d","article-title":"Why rectal douches may be acceptable rectal-microbicide delivery vehicles for men who have sex with men","volume":"37","author":"Carballo-Dieguez","year":"2010","journal-title":"Sex Transm. Dis."},{"key":"10.1016\/j.ejpb.2018.05.030_b0055","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1089\/aid.2013.0189","article-title":"Isoosmolar enemas demonstrate preferential gastrointestinal distribution, safety, and acceptability compared with hyperosmolar and hypoosmolar enemas as a potential delivery vehicle for rectal microbicides","volume":"29","author":"Leyva","year":"2013","journal-title":"Aids Res. Hum. Retrov."},{"key":"10.1016\/j.ejpb.2018.05.030_b0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jconrel.2014.10.026","article-title":"Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse","volume":"197","author":"Maisel","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejpb.2018.05.030_b0065","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI106100","article-title":"Effects of sodium concentration and osmolality on water and electrolyte absorption form the intact human colon","volume":"48","author":"Billich","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejpb.2018.05.030_b0070","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1089\/aid.2013.0044","article-title":"Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue","volume":"29","author":"Louissaint","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.ejpb.2018.05.030_b0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/aid.2015.0182","article-title":"Dose Frequency ranging pharmacokinetic study of tenofovir-emtricitabine after directly observed dosing in healthy volunteers to establish adherence benchmarks (HPTN 066)","volume":"32","author":"Hendrix","year":"2016","journal-title":"Aids Res. Hum. Retrov."},{"key":"10.1016\/j.ejpb.2018.05.030_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055013","article-title":"MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments","volume":"8","author":"Hendrix","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.ejpb.2018.05.030_b0085","unstructured":"Guidance for Industry: Bioanalytical Method Validation, in: U.S.D.o.H.a.H. Services (Ed.), 2001."},{"key":"10.1016\/j.ejpb.2018.05.030_b0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01062139","article-title":"Testing for the equality of area under the curves when using destructive measurement techniques","volume":"16","author":"Bailer","year":"1988","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejpb.2018.05.030_b0095","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1089\/aid.2012.0262","article-title":"RMP-02\/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate","volume":"28","author":"Anton","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.ejpb.2018.05.030_b0100","doi-asserted-by":"crossref","first-page":"e0125363","DOI":"10.1371\/journal.pone.0125363","article-title":"A Phase 1 randomized, open label, rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of three formulations of tenofovir 1% Gel (the CHARM-01 Study)","volume":"10","author":"McGowan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.05.030_b0105","doi-asserted-by":"crossref","first-page":"e106196","DOI":"10.1371\/journal.pone.0106196","article-title":"A multi-compartment single and multiple dose pharmacokinetic comparison of rectally applied tenofovir 1% gel and oral tenofovir disoproxil fumarate","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2018.05.030_b0110","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01644-17","article-title":"Hypo-osmolar formulation of tenofovir (TFV) enema promotes uptake and metabolism of TFV in tissues, leading to prevention of SHIV\/SIV infection","volume":"62","author":"Xiao","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2018.05.030_b0115","first-page":"89","article-title":"Personalized contraceptive counseling: helping women make the right choice","volume":"7","author":"Rodriguez","year":"2016","journal-title":"Open Access J. Contracept."},{"key":"10.1016\/j.ejpb.2018.05.030_b0120","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/AAC.45.10.2733-2739.2001","article-title":"Phase i\/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults","volume":"45","author":"Barditch-Crovo","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2018.05.030_b0125","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.42.3.612","article-title":"Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA","volume":"42","author":"Robbins","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2018.05.030_b0130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1081\/NCN-100002496","article-title":"Metabolism of GS-7340, a novel phenyl monophosphoramidate intracellular prodrug of PMPA, in blood","volume":"20","author":"Eisenberg","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ejpb.2018.05.030_b0135","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/AAC.49.5.1898-1906.2005","article-title":"Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue","volume":"49","author":"Lee","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2018.05.030_b0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/QAI.0b013e3182965d45","article-title":"Antiviral activity, safety, and pharmacokinetics\/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults","volume":"63","author":"Ruane","year":"2013","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ejpb.2018.05.030_b0145","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1128\/AAC.00068-10","article-title":"Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside\/nucleotide-resistant HIV","volume":"54","author":"Lanier","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2018.05.030_b0150","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/gut.43.2.294","article-title":"Salt and water absorption in the human colon: a modern appraisal","volume":"43","author":"Sandle","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.ejpb.2018.05.030_b0155","unstructured":"Pre-exposure prophylaxis for the prevention of HIV in the United States - 2014: A clinical practice guideline, in: C.f.D.C.a. Prevention (Ed.), 2014."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118304764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118304764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T03:09:52Z","timestamp":1661310592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118304764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":31,"alternative-id":["S0939641118304764"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.05.030","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2018.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}